查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1864488

心臟輔助設備市場按產品類型、操作模式、臨床應用、治療持續時間和最終用戶分類－2025-2032年全球預測

Cardiac Assist Devices Market by Product Type, Mode Of Operation, Clinical Application, Therapy Duration, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟輔助設備市場規模將達到 26.3 億美元，複合年成長率為 6.76%。

主要市場統計數據
基準年 2024 15.5億美元
預計年份：2025年 16.6億美元
預測年份：2032年 26.3億美元
複合年成長率 (%) 6.76%

全面介紹心臟輔助設備，重點關注臨床進展、技術融合以及相關人員的策略重點。

心臟輔助裝置已從一種小眾的救命療法發展成為現代晚期心臟衰竭治療的核心組成部分。過去二十年間，裝置的小型化、外科技術的進步以及術後護理的改善改變了臨床預期，並擴大了可從機械循環支持中獲益的患者群體。同時，影像學、血流動力學監測和抗凝血管理技術的進步進一步提高了手術安全性，並使得更早、更果斷的臨床介入成為可能。

深入分析技術、臨床和報銷變革的交匯點，這些變革正在重塑心臟支援設備創新和醫療保健服務。

由於技術、臨床實踐和醫療保健系統經濟等多方面因素的融合，心臟輔助裝置領域正經歷著變革性的轉變。幫浦組件的小型化和經皮入路技術的改進，正在拓展微創支持的適應症範圍，使急性補償患者能夠早期療育，並提供可在傳統手術室外實施的過渡治療策略。同時，臨床醫生正在基於改進的風險分層工具和生物標記修訂患者選擇標準，從而進一步實現裝置選擇和治療時機的個人化。

2025年美國關稅調整及其對心臟輔助設備供應鏈和籌資策略的策略影響的累積分析

美國宣布的2025年一系列關稅調整將對心臟輔助設備生態系統的供應鏈設計、採購決策和採購策略產生實際影響。依賴國際供應鏈採購精密零件、泵浦組件或專用耗材的製造商，如果無法吸收或將關稅帶來的成本上漲轉嫁給買家，可能會面臨利潤率下降。因此，醫療系統和集團採購組織的採購團隊可能會更密切地審查總交付成本，而供應商則可能重新評估合約條款和對沖策略以管理風險。

關鍵細分洞察突顯了最終用戶對產品類型、作用機制、臨床應用、治療持續時間和採用情況的影響。

嚴謹的細分框架闡明了產品系列、運作模式、臨床目標、治療時間長度和最終用戶如何相互作用，從而影響部署管道和研發優先順序。根據產品類型，設備類別涵蓋雙心室輔助裝置、左心室輔助裝置、經皮心室輔助裝置、右心室輔助裝置和全人工心臟。經經皮輔助裝置再按平台進一步細分，例如 Impella 和 TandemHeart，每個產品類型都有其獨特的臨床應用情境、手術流程和服務預期，這些都會影響醫療機構的部署優先順序。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大微創心室輔助裝置在老年患者的應用
  • 將人工智慧整合到心臟輔助設備中以進行預測分析
  • 透過開發生物相容性材料來減少心臟輔助裝置（VAD）的血栓併發症
  • 擴大攜帶式家用體外膜氧合（ECMO）系統的應用
  • 磁浮泵浦技術的出現提高了設備的耐久性
  • 人們越來越關注用於治療先天性心臟疾病的兒童心臟輔助裝置
  • 無線電力傳輸技術的進步，無需經皮驅動線
  • 監管部門的核准將促進新一代人工心臟的廣泛應用
  • 醫療設備製造商與醫院網路建立合作夥伴關係，建構一體化醫療服務路徑
  • 加大對用於循環支持應用的奈米流體泵系統的研究投入

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 心臟輔助設備市場（依產品類型分類）

  • 雙心室輔助裝置
  • 左心室輔助裝置
  • 經皮心室輔助裝置
    • 葉輪
    • 串聯心臟
  • 右心輔助裝置
  • 人工心臟

9. 依操作模式分類的心臟輔助設備市場

  • 連續流
    • 軸向流
    • 離心流
  • 脈動流

10. 依臨床應用分類的心臟輔助設備市場

  • 通往復健的橋樑
  • 移植橋樑
  • 治療目的

第11章：按治療持續時間分類的心臟輔助設備市場

  • 長期
  • 短期

第12章：依最終使用者分類的心臟輔助設備市場

  • 醫院
  • 專科診所

13. 各地區心臟輔助設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：心臟輔助設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國心臟輔助設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abiomed, Inc.
    • Medtronic plc
    • Abbott Laboratories
    • Getinge AB
    • Terumo Corporation
    • LivaNova PLC
    • Teleflex Incorporated
    • Nipro Corporation
    • ZOLL Medical Corporation
    • Levitronix GmbH
Product Code: MRR-F97DD5A7DF05

The Cardiac Assist Devices Market is projected to grow by USD 2.63 billion at a CAGR of 6.76% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.55 billion
Estimated Year [2025] USD 1.66 billion
Forecast Year [2032] USD 2.63 billion
CAGR (%) 6.76%

Comprehensive introduction to cardiac assist devices highlighting clinical evolution, technology convergence, and strategic priorities for stakeholders

Cardiac assist devices have evolved from niche rescue therapies into central components of contemporary advanced heart failure management. Over the past two decades, improvements in device miniaturization, surgical technique, and postoperative care have shifted clinical expectations and broadened the pool of patients who may benefit from mechanical circulatory support. Concurrent advances in imaging, hemodynamic monitoring, and anticoagulation management have further increased the procedural safety profile, enabling earlier and more decisive clinical interventions.

Clinicians now integrate device selection and timing into multidisciplinary care pathways that include heart failure specialists, cardiac surgeons, intensivists, and rehabilitation teams. This integrated model emphasizes patient-centered endpoints such as functional recovery, quality of life, and reduction of rehospitalizations alongside traditional survival metrics. Device developers have responded with modular product families, hybrid approaches bridging temporary to durable support, and user-centered incremental innovations that reduce implantation complexity.

Regulators and payers have likewise adapted, instituting evidence frameworks and real-world data collection that inform reimbursement sequences and coverage policies. Consequently, technology developers must now navigate not only engineering and clinical hurdles but also the expanding expectations of health systems for demonstrable outcomes. As stakeholders assess strategic options, understanding the interplay between clinical need, device capability, and system-level constraints becomes critical for making informed decisions about investment, adoption, and clinical protocol evolution.

In-depth analysis of converging technological, clinical, and reimbursement shifts reshaping cardiac assist device innovation and care delivery

The landscape for cardiac assist devices is undergoing transformative shifts driven by converging forces across technology, clinical practice, and health system economics. Miniaturization of pump components and the refinement of percutaneous access techniques have expanded indications for less invasive support, enabling earlier intervention in acutely decompensated patients and offering bridge strategies that can be deployed outside traditional operating rooms. Concurrently, clinicians are recalibrating patient selection criteria based on improved risk stratification tools and biomarkers, which has led to more personalized device choices and therapy timing.

In parallel, data-driven monitoring and remote telemetry have redefined post-implant care, facilitating outpatient management protocols and reducing hospital length of stay. These capabilities have important implications for device design and service models, shifting some value propositions from device durability alone toward integrated solutions encompassing remote monitoring, predictive maintenance, and digital care workflows. Reimbursement models are adapting, with increasing emphasis on bundled care outcomes and value-based arrangements that prioritize quality metrics and total cost of care rather than procedural volume.

Finally, the competitive landscape is evolving as established implantable device manufacturers, surgical device specialists, and new entrants with expertise in transcatheter systems converge. This competitive convergence has intensified partnerships, licensing agreements, and targeted acquisitions intended to bridge gaps across therapy duration, access modality, and clinical application. As a result, stakeholders must adopt adaptive strategies that anticipate continued technological refinement and shifting care delivery expectations.

Cumulative analysis of 2025 United States tariff adjustments and their strategic implications for cardiac assist device supply chains and procurement strategies

The set of tariff adjustments announced for 2025 in the United States introduces tangible implications for supply chain design, sourcing decisions, and procurement strategy across the cardiac assist device ecosystem. Manufacturers that rely on international supply chains for precision components, pump assemblies, or proprietary consumables may experience margin compression if tariff-induced cost increases cannot be absorbed or passed through to purchasers. Consequently, procurement teams within health systems and group purchasing organizations are likely to scrutinize total delivered cost more closely, while suppliers may revisit contract terms and hedging strategies to manage exposure.

These tariff adjustments also affect strategic manufacturing footprints. Some companies will consider nearshoring critical components or expanding domestic manufacturing capacity to mitigate tariff sensitivity and improve supply continuity. Such shifts require capital allocation, regulatory revalidation of production sites, and potential reconfiguration of logistics networks, all of which have lead times that extend beyond immediate procurement cycles. In the near term, contractual renegotiation and volume-based sourcing arrangements will be important levers for both suppliers and buyers to preserve access and control pricing volatility.

Clinicians and hospital administrators should anticipate potential downstream effects on device availability and value-based contracting. To navigate this environment, cross-functional teams that include supply chain, clinical leadership, and contracting specialists should develop scenario plans that balance short-term operational continuity with long-term strategic resilience. By doing so, organizations can protect patient access to critical therapies while positioning themselves to benefit from supply chain optimization opportunities that arise from tariff-driven adjustments.

Key segmentation insights that delineate product types, operational modalities, clinical applications, therapy durations, and end-user implications for adoption

A rigorous segmentation framework clarifies how product families, operational modes, clinical intent, therapy duration, and end users interact to shape adoption pathways and development priorities. Based on product type, device categories range from biventricular assist devices and left ventricular assist devices to percutaneous ventricular assist devices, right ventricular assist devices, and total artificial hearts, with percutaneous options further differentiated by platforms such as Impella and TandemHeart; each product category presents distinct clinical use cases, procedural workflows, and service expectations that influence how institutions prioritize adoption.

Based on mode of operation, devices are studied across continuous flow and pulsatile flow technologies, with continuous flow devices further segmented into axial flow and centrifugal flow architectures; these operational distinctions carry implications for hemocompatibility, thrombosis risk, and long-term durability considerations, and therefore influence clinician selection and post-implant management strategies. Based on clinical application, therapeutic roles include bridge to recovery, bridge to transplant, and destination therapy, each with unique registry requirements, outcome endpoints, and patient counseling priorities that affect device evaluation criteria.

Based on therapy duration, understanding contrasts between long-term and short-term use cases helps align product engineering with anticipated clinical pathways and follow-up needs, and based on end user, recognizing differences in utilization across hospitals and specialty clinics clarifies service models, training priorities, and capital acquisition approaches. Together, these cross-cutting segmentation lenses provide a structured way to evaluate technology fit, clinical workflow integration, and long-term support obligations.

Comprehensive regional insights outlining how regulatory, reimbursement, and clinical ecosystem differences shape cardiac assist device adoption across global regions

Regional dynamics significantly influence regulatory approaches, reimbursement paradigms, clinician practice patterns, and supply chain design, creating differentiated pathways for device commercialization and adoption. In the Americas, advanced cardiac centers continue to drive early adoption of minimally invasive and durable support strategies, supported by robust clinical registries, evolving coverage policies, and concentration of specialized surgical expertise; this environment favors technologies that demonstrate clear improvements in clinical outcomes and reductions in rehospitalization burden.

In Europe, the Middle East & Africa, regulatory harmonization efforts and national procurement frameworks shape pricing and access differently across jurisdictions, while pockets of clinical excellence in major metropolitan centers serve as hubs for advanced device adoption and investigator-led trials. Stakeholders operating in these regions must adapt to heterogeneous reimbursement landscapes and develop differentiated engagement strategies for national health services and private payers.

In Asia-Pacific, dynamic healthcare investment, expanding specialty care infrastructure, and rising cardiovascular disease burden create significant demand for scalable device solutions and services. However, regional regulatory timelines, reimbursement design, and local manufacturing preferences can materially affect go-to-market strategies. Across all regions, nuanced approaches to clinician education, local evidence generation, and post-market surveillance are essential to secure durable adoption and to align product support models with regional health system capabilities.

Strategic company-level insights revealing product innovation trends, collaborative partnerships, and service model evolution among device developers

Key industry participants are pursuing complementary strategies that encompass product innovation, service expansion, and collaborative arrangements with clinical centers to accelerate evidence generation and deployment. Leading device manufacturers are investing in iterative improvements to pump design, biocompatible materials, and integrated sensing to reduce complications and simplify implantation. At the same time, surgical device specialists and transcatheter innovators are exploring hybrid techniques and simplified access platforms that lower procedural complexity and broaden the range of eligible operators.

Partnerships between device developers and digital health vendors are increasing to enable remote monitoring, predictive maintenance algorithms, and patient engagement tools that extend the value proposition beyond the implant procedure. Several companies are also expanding service footprints to include training academies, simulation-based operator credentialing, and bundled service offerings that reduce institutional adoption friction. Strategic alliances with large health systems and academic centers are facilitating real-world evidence generation and registry development, which supports clinical guideline incorporation and payer discussions.

Emerging entrants with strengths in minimally invasive delivery or component manufacturing are prompting incumbents to reassess competitive postures, often resulting in licensing agreements or targeted acquisitions. For procurement teams and corporate strategists, tracking these moves provides early signals about future product roadmaps, integration priorities, and potential new service models that could alter procurement criteria and clinical workflows.

Actionable recommendations for industry leaders to enhance product relevance, supply chain resilience, evidence generation, and service-based commercial models

Industry leaders should prioritize a set of actionable initiatives to maintain clinical relevance, protect margins, and accelerate adoption within constrained procurement environments. First, invest in modular product strategies that allow incremental upgrades to key subsystems, such as controllers and sensors, reducing the need for full-system replacement while improving the lifetime value proposition for hospitals. Second, develop comprehensive evidence plans that extend beyond pivotal trials to include registries, real-world outcomes, and health economic analyses that speak directly to payer and hospital procurement concerns.

Third, strengthen supply chain resilience through dual sourcing, nearshoring critical components, and strategic inventory policies to mitigate tariff and logistics-related disruptions. Fourth, expand service offerings to include training, remote monitoring, and lifecycle maintenance programs that reduce institutional barriers to adoption and create recurring revenue streams. Fifth, engage proactively with regulators and payers to clarify evidence expectations and to pilot value-based contracting arrangements that align incentives across stakeholders.

Finally, cultivate clinician partnerships through centers of excellence, investigator-initiated trial support, and co-development arrangements that prioritize user experience and workflow integration. By executing these initiatives in parallel, industry leaders can better align product development with health system demands, buffer against supply chain shocks, and accelerate meaningful clinical uptake.

Transparent and multi-source research methodology combining primary clinician interviews, registry analysis, regulatory review, and scenario-based assessments

The research methodology integrates multiple evidence streams to ensure robust, reproducible insights that are actionable for clinical, commercial, and regulatory stakeholders. Primary research includes structured interviews with cardiac surgeons, heart failure specialists, interventional cardiologists, and procurement leaders to capture frontline perspectives on device performance, procedural workflows, and adoption barriers. These qualitative inputs are triangulated with clinical literature reviews, peer-reviewed trial outcomes, and device registries to validate efficacy and safety characteristics across device categories and clinical applications.

Secondary data sources include regulatory filings, real-world evidence datasets, and technology whitepapers that provide context on device approvals, post-market surveillance findings, and evolving standard-of-care benchmarks. The methodology also uses scenario analysis and sensitivity assessments to explore the operational and financial implications of supply chain disruptions, regulatory changes, and reimbursement shifts. Throughout the process, findings are subjected to internal peer review by clinical and technical experts to ensure interpretive rigor and to minimize bias.

Transparency is maintained by documenting data sources, interview protocols, and analytical assumptions, while confidentiality safeguards protect participating clinicians and institutions. The resulting methodological approach balances depth of clinical validity with practical applicability, enabling stakeholders to translate insights into strategy, trial design input, and procurement planning.

Concise conclusion synthesizing technology advances, supply chain realities, clinical pathway implications, and strategic imperatives for stakeholders

Synthesis of the preceding analyses points to a cardiac assist device environment that is simultaneously technologically vibrant and operationally complex, with multiple interdependent forces shaping near-term choices and long-term strategy. Technological advances in percutaneous delivery and continuous flow architectures are expanding procedural possibilities and recalibrating clinical decision-making, while data-enabled care models are altering post-implant expectations and creating opportunities for value-added services that extend beyond the physical device.

At the same time, supply chain dynamics, including tariff effects and component sourcing decisions, are imposing new considerations on procurement and cost management. Regional regulatory and reimbursement heterogeneity requires differentiated commercialization roadmaps, and company strategies that emphasize partnerships, evidence generation, and service models are likely to be more resilient. For clinical leaders, aligning multidisciplinary care pathways and investing in training will be essential to capture the full potential of these technologies in improving patient-centered outcomes.

Overall, stakeholders who integrate device innovation with robust evidence generation, resilient supply chain planning, and service-oriented commercial approaches will be better positioned to deliver sustained clinical impact and operational value across diverse health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of minimally invasive ventricular assist devices in elderly patients
  • 5.2. Integration of artificial intelligence in cardiac assist devices for predictive analytics
  • 5.3. Development of biocompatible materials to reduce thrombotic complications in VADs
  • 5.4. Expansion of portable extracorporeal membrane oxygenation systems for home use
  • 5.5. Emergence of magnetically levitated pump technology to improve device durability
  • 5.6. Increasing focus on pediatric-specific cardiac assist devices for congenital heart disease
  • 5.7. Advancements in wireless power transmission to eliminate percutaneous drive lines
  • 5.8. Regulatory approvals accelerating availability of next generation total artificial hearts
  • 5.9. Collaborative partnerships between device manufacturers and hospital networks for integrated care pathways
  • 5.10. Rising investments in research for nanofluidic pump systems in circulatory support applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Assist Devices Market, by Product Type

  • 8.1. Biventricular Assist Device
  • 8.2. Left Ventricular Assist Device
  • 8.3. Percutaneous Ventricular Assist Device
    • 8.3.1. Impella
    • 8.3.2. TandemHeart
  • 8.4. Right Ventricular Assist Device
  • 8.5. Total Artificial Heart

9. Cardiac Assist Devices Market, by Mode Of Operation

  • 9.1. Continuous Flow
    • 9.1.1. Axial Flow
    • 9.1.2. Centrifugal Flow
  • 9.2. Pulsatile Flow

10. Cardiac Assist Devices Market, by Clinical Application

  • 10.1. Bridge To Recovery
  • 10.2. Bridge To Transplant
  • 10.3. Destination Therapy

11. Cardiac Assist Devices Market, by Therapy Duration

  • 11.1. Long Term
  • 11.2. Short Term

12. Cardiac Assist Devices Market, by End User

  • 12.1. Hospitals
  • 12.2. Specialty Clinics

13. Cardiac Assist Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cardiac Assist Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Assist Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abiomed, Inc.
    • 16.3.2. Medtronic plc
    • 16.3.3. Abbott Laboratories
    • 16.3.4. Getinge AB
    • 16.3.5. Terumo Corporation
    • 16.3.6. LivaNova PLC
    • 16.3.7. Teleflex Incorporated
    • 16.3.8. Nipro Corporation
    • 16.3.9. ZOLL Medical Corporation
    • 16.3.10. Levitronix GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. CARDIAC ASSIST DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. CARDIAC ASSIST DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIAC ASSIST DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY IMPELLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TANDEMHEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY LONG TERM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SHORT TERM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CARDIAC ASSIST DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 280. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 281. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 282. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 283. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 284. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 285. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 288. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 289. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GCC CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY PERCUTANEOUS VENTRICULAR ASSIST DEVICE, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY CONTINUOUS FLOW, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY THERAPY DURATION, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION CARDIAC ASSIST DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS CARDIAC ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS CARDIAC ASSIST DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-